Medicines : mere generic facts

Abstract

Originator and generic medicines are often identified either by their generic name or their brand name. Good Manufacturing Practice (GMP) standards ensure that medicines are of high quality, and thus support policies of generic prescribing and generic substitution. The substitution model adopted in Malta promotes rational use and favours competition between different brands. Competition is essential for inducing innovation of medicines and for the sustainability of the pharmaceutical industry. The availability of medicines, the knowledge on these medicines and confidence in their use, are crucial for the rational use of medicines as well as for the strengthening of the medicines market.